Paul Stockdale
Fortune : 9 489 $ au 31/07/2026
Fortune : 9 489 $ au 31/07/2026
Paul Stockdale currently works at Oxford BioDynamics Plc, as Chief Financial Officer & Executive Director.
Mr. Stockdale also formerly worked at e-Therapeutics Plc, as Financial Controller from 2012 to 2017 and Deloitte & Touche LLP UK, as Senior Manager from 1996 to 2004.
Mr. Stockdale received his graduate degree from the University of Cambridge.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OXFORD BIODYNAMICS PLC 0,15 % | 10/11/2025 | 6 411 252 ( 0,15 % ) | 9 489 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Directeur Financier/CFO | 15/09/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| E-THERAPEUTICS PLC | Comptroller/Controller/Auditor | 01/09/2017 |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides business consulting, audit & assurance, tax, financial advisory and legal services | Corporate Officer/Principal | 01/01/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
e-Therapeutics Plc
e-Therapeutics Plc BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides business consulting, audit & assurance, tax, financial advisory and legal services | Commercial Services |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national